FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia ...

Mission Bio's Tapestri Enables Single-Cell Profiling of Residual Disease, Identifying AML Patients Likely to Benefit from Motixafortide in the Multicenter BLAST Trial

SOUTH SAN FRANCISCO, Calif. & HEIDELBERG, Germany, June 03, 2026--Mission Bio, a leader in single-cell multiomics, jointly ...

Little-tested spinal cord treatment triggers hope, hype and lawsuits in Brazil

An experimental treatment for spinal cord injuries has ignited a frenzy in Brazil, drawing patients from as far off as Mexico ...
Medical Dialogues

VERVE-102 Gene-Editing Therapy Shows Promise in LDL Reduction: NEJM

VERVE-102 is an investigational gene-editing treatment designed to permanently disable the PCSK9 gene in the liver, thereby ...
Fierce Pharma

As Akeso takes center stage at ASCO, China biotech industry cements its coming of age

Nearly a decade later, taking the center stage at ASCO 2026, Akeso’s ivonescimab made history by offering the first-ever ...
Pharmabiz

MSD’s Enflonsia receives Singapore HSA approval for prevention of RSV lower respiratory tract disease in infants born during or entering their first RSV season

MSD’s Enflonsia receives Singapore HSA approval for prevention of RSV lower respiratory tract disease in infants born during or entering their first RSV season: Singapore Wednes ...

Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion

Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
The Manila Times

Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses

Data presentations across multiple kidney diseases illustrate the breadth of Biogen’s nephrology portfolio with EMPAVELI® (pegcetacoplan) and felzartamab, an investigational anti-CD38 monoclonal ...

Cells have a built-in 'seatbelt' against sudden stress

When cells experience sudden physical stress, like stretching or pressure, they can activate a fast, protective mechanism ...
BMJ Open

Diurnal variations to proinflammatory markers in individuals with diabetes compared to healthy controls: protocol for a systematic review and meta-analysis

Introduction Diabetes mellitus is a highly prevalent metabolic disorder associated with chronic, low-grade inflammation. Of recent interest is the association between diabetes and circadian rhythm ...